How can counting cancer cells in the blood make a difference in treatment? Can a potent hormone that fuels some breast cancers be used to fire back against the disease? These critical questions are being answered via innovative laboratory and clinical research underway at Georgetown Lombardi Comprehensive Cancer Center. A renowned pharmacologist who discovered a leading treatment for cancer and a physician treating patients in cutting edge clinical trials will discuss these and other life-enhancing discoveries during Doctors Speak Out, a series of conversations with physicians and researchers on today’s most pressing health issues.
In this installment of the Doctors Speak Out series, a distinguished panel of Georgetown physicians and researchers will detail research and treatment customized to an individual’s unique body make-up and the emergence of “systems medicine” – an approach based on the interplay of genes, environment and high-tech computation. Other topics include ways of expediting laboratory discoveries to benefit cancer patients, a new emphasis on preventative, holistic approaches to medicine, and the dawn of a retooled relationship of more equally shared responsibility between patient and physician.
DASH diet may lower the risk of cardiovascular disease in breast cancer survivors